Diosynth

Diosynth

Diosynth is a company that develops manufacturing processes for active ingredients for pharmaceutical companies all over the world.[1] The company started in Oss, Netherlands[2] in 1923 with the extraction of insulin from bovine pancreas, and porcine insulin extraction in 1930, both of which are still part of their main products.[3][4][5] As of January 1, 2005, this company is a part of Organon.[6] Diosynth along with its sister companies, Organon and Intervet were part of the Akzo Nobel pharma group until their sale to Schering-Plough in March 2007.[7] Schering-Plough merged with Merck & Co. March 9, 2009[8]

References